The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

St. Jude researchers advance CASTs, enhancing precision and activity for next-generation genome-editing therapies.

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

An international research team led by Hiroki Shibuya at RIKEN Center for Biosystems Dynamics Research (BDR) in Japan has ...

MIT researchers discovered that the genome’s 3D structure doesn’t vanish during cell division as previously thought. Instead, ...

Researchers have developed an improved method of gene editing that is precise, more efficient than other similar methods and ...